FutureMeds moves into the top tier of Dedicated Site Networks in Central and Eastern Europe.

FutureMeds presence in the U.K. and our network of medical research clinics will unlock an accelerated, 4 times more efficient trial process

FutureMeds are delighted to announce the acquisition of KCM, a leading clinical trial site based in Krakow, Poland. KCM was founded in...

We are extremely proud to welcome Christophe Berthoux as Chairman of FutureMeds and are excited to bring his vast amount of global...

FutureMeds, a UK based Dedicated Research Sites Network announces the appointment of Dr Radoslaw Janiak as its Chief Executive Officer....

FutureMeds, a new independent Site Management Organisation, has opened its first site in Wroclaw, Poland.  The site is the first of a...